| Symbol: |
C17orf67
|
| Description: |
chromosome 17 open reading frame 67 [Source:HGNC Symbol;Acc:27900]
|
| Location: |
Chr17:54869274-54916134[-]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:81
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| C17orf67 |
Lobinaline, monohydrochloride |
0.036 |
Up |
| C17orf67 |
Cromolyn sodium |
0.048 |
Down |
| C17orf67 |
NSC 13477 |
0.041 |
Up |
| C17orf67 |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.015 |
Up |
| C17orf67 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.027 |
Up |
| C17orf67 |
Buclizine Hydrochloride |
0.047 |
Up |
| C17orf67 |
Methanaminium, N-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,2-benzenedicarboxylate (1:1) |
0.006 |
Up |
| C17orf67 |
Chlorazin |
0.036 |
Up |
| C17orf67 |
NSC 310547 |
0.025 |
Down |
| C17orf67 |
NSC 328130 |
0.006 |
Up |
| C17orf67 |
CYTOVARICIN |
0.023 |
Up |
| C17orf67 |
Piperidine, 2,6-diphenyl-1-methyl-4-[(phenylmethoxy)imino]-, cis- |
0.027 |
Up |
| C17orf67 |
Myricitin |
0.046 |
Up |
| C17orf67 |
Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt |
0.031 |
Down |
| C17orf67 |
NSC 611074 |
0.033 |
Down |
Expression pattern: Sensitivity / Resistance
Total:6 Current:1
[First] [Prev] Next Last
|
| SNP:
~ Export ~
|
Records:13
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
| miRNA:
~ Export ~
|
Records:null
| Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|